Skip to content
OpenCapital
Get started

Pacira BioSciences, Inc. PCRX EBITDA

EBITDA at other companies

Avanos Medical logo
Avanos MedicalAVNS
$19.1M-4.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$86.83M+11.0%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-16.0%
Enterprise value$1.21B+1.2%
P/E183.5×—
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Calculated from Pacira BioSciences, Inc.’s reported figures.

$6.9Mebit+
$21.3MDepreciation Depletion & Amortization
=$28.23M

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s EBITDA?
Pacira BioSciences, Inc. (PCRX) reported EBITDA of $28.23M in Q1 2026.
How has Pacira BioSciences, Inc.'s EBITDA changed year-over-year?
Pacira BioSciences, Inc.'s EBITDA increased by 21.9% year-over-year, from $23.16M to $28.23M.
What is the long-term trend for Pacira BioSciences, Inc.'s EBITDA?
Over 2 years (2021 to 2025), Pacira BioSciences, Inc.'s EBITDA has grown at a -3.5% compound annual growth rate (CAGR), from $118.47M to $110.21M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.